RAYMOND JAMES & ASSOCIATES - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 19 filers reported holding PLX PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of PLX PHARMA INC
ValueSharesWeighting
Q4 2021$533,000
-71.4%
66,558
-31.1%
0.00%
-100.0%
Q3 2021$1,865,000
+49.3%
96,619
+6.7%
0.00%
+100.0%
Q2 2021$1,249,000
+36.1%
90,530
-11.0%
0.00%0.0%
Q1 2021$918,000
+2139.0%
101,713
+873.5%
0.00%
Q2 2018$41,0000.0%10,448
-13.9%
0.00%
Q1 2018$41,000
-48.8%
12,130
+4.3%
0.00%
Q4 2017$80,00011,6300.00%
Other shareholders
PLX PHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$403,0000.96%
Park West Asset Management LLC 1,075,723$6,918,0000.41%
683 Capital Management, LLC 249,300$1,603,0000.17%
Heritage Way Advisors, LLC 28,000$180,0000.15%
Harel Insurance Investments & Financial Services Ltd. 250,000$145,0000.01%
UBS Group AG 11,840$76,0000.00%
BANK OF AMERICA CORP /DE/ 2$00.00%
WELLS FARGO & COMPANY/MN 1,302$8,0000.00%
FAYEZ SAROFIM & CO 13,729$89,0000.00%
DEUTSCHE BANK AG\ 2$00.00%
View complete list of PLX PHARMA INC shareholders